Niche expertise Concentrics Research specializes in late-stage (Phase II-IV) and consumer healthcare research with a unique site for early iterative testing and single site testing. This positions them well for sponsors seeking efficient, high-precision CRO support in complex clinical programs.

Rx to OTC strength With over 30 years of Rx-to-OTC switch experience, they can offer strategic guidance and execution for brands looking to navigate regulatory pathways and market re-entry, enabling upsell opportunities for lifecycle management projects.

Integrated divisions The combination of a clinical division and a regulated healthcare market research division allows cross-selling opportunities to clients needing both clinical outcomes and market insights, increasing project scope per sponsor relationship.

Compact agility As a smaller CRO (11-50 employees) operating within a large ecosystem of big competitors, they can compete on speed, flexibility, and customized solutions for mid-sized pharma, biotech, and consumer health brands seeking tailored engagement.

Growth signals Revenue in the lower mid-range and a clear niche focus suggest opportunity to expand services through strategic partnerships, expanded-site testing capabilities, and longer-term study pipelines with existing and new clients in consumer healthcare and late-stage trials.